FI114781B - Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita - Google Patents

Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita Download PDF

Info

Publication number
FI114781B
FI114781B FI942184A FI942184A FI114781B FI 114781 B FI114781 B FI 114781B FI 942184 A FI942184 A FI 942184A FI 942184 A FI942184 A FI 942184A FI 114781 B FI114781 B FI 114781B
Authority
FI
Finland
Prior art keywords
ebv
peptide
ebna
peptides
antibodies
Prior art date
Application number
FI942184A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942184A (fi
FI942184A0 (fi
Inventor
Jaap Michiel Middeldorp
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI942184A publication Critical patent/FI942184A/fi
Publication of FI942184A0 publication Critical patent/FI942184A0/fi
Application granted granted Critical
Publication of FI114781B publication Critical patent/FI114781B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/087—Herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI942184A 1992-09-14 1994-05-11 Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita FI114781B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92202797 1992-09-14
EP92202797 1992-09-14
PCT/EP1993/002478 WO1994006912A1 (fr) 1992-09-14 1993-09-13 Peptides du virus d'epstein-barr et anticorps diriges contre ces peptides
EP9302478 1993-09-13

Publications (3)

Publication Number Publication Date
FI942184A FI942184A (fi) 1994-05-11
FI942184A0 FI942184A0 (fi) 1994-05-11
FI114781B true FI114781B (fi) 2004-12-31

Family

ID=8210912

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942184A FI114781B (fi) 1992-09-14 1994-05-11 Epstein-Barr-viruksen peptidejä ja näitä peptidejä vastaan suunnattuja vasta-aineita

Country Status (13)

Country Link
US (1) US5965353A (fr)
EP (1) EP0607425B1 (fr)
JP (3) JP4155591B2 (fr)
KR (1) KR100384250B1 (fr)
AT (1) ATE266728T1 (fr)
AU (1) AU667745B2 (fr)
CA (1) CA2120342C (fr)
DE (1) DE69333511T2 (fr)
DK (1) DK0607425T3 (fr)
ES (1) ES2221922T3 (fr)
FI (1) FI114781B (fr)
HK (1) HK1001461A1 (fr)
WO (1) WO1994006912A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888458B1 (en) * 1993-11-30 2011-02-15 John B. Harley Diagnostics and therapy of epstein-barr virus in autoimmune disorders
WO1996002563A1 (fr) * 1994-07-13 1996-02-01 Cornell Research Foundation, Inc. Proteine de l'antigene nucleaire 1 du virus epstein barr, son expression et sa recuperation
US7273613B1 (en) 1997-01-13 2007-09-25 The Board of Regents, The University of Oklahoma Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
AU766165B2 (en) * 1997-01-13 2003-10-09 Oklahoma Medical Research Foundation Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
ITMI20010445A1 (it) 2001-03-05 2002-09-05 Enitecnologie Spa Dispersioni acquose di residui petroliferi pesanti
AU2003246485A1 (en) * 2002-07-16 2004-02-02 Affinium Pharmaceuticals, Inc. Interactions of the epstein-barr virus protein ebna1, and uses thereof
WO2022146869A1 (fr) * 2020-12-29 2022-07-07 The Board Of Trustees Of The Leland Stanford Junior University Agents diagnostiques et thérapeutiques pour le virus epstein-barr (ebv) en sclérose en plaques (sep) et autres maladies auto-immunes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5717065A (en) * 1984-08-08 1998-02-10 The Scripps Research Institute Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット

Also Published As

Publication number Publication date
WO1994006912A1 (fr) 1994-03-31
CA2120342A1 (fr) 1994-03-31
DE69333511T2 (de) 2005-05-12
ES2221922T3 (es) 2005-01-16
JPH07501710A (ja) 1995-02-23
FI942184A (fi) 1994-05-11
ATE266728T1 (de) 2004-05-15
US5965353A (en) 1999-10-12
JP4155591B2 (ja) 2008-09-24
DK0607425T3 (da) 2004-09-20
JP4957974B2 (ja) 2012-06-20
AU4816293A (en) 1994-04-12
FI942184A0 (fi) 1994-05-11
JP2008273972A (ja) 2008-11-13
KR100384250B1 (ko) 2003-12-24
EP0607425B1 (fr) 2004-05-12
HK1001461A1 (en) 1998-06-19
EP0607425A1 (fr) 1994-07-27
JP2009280589A (ja) 2009-12-03
AU667745B2 (en) 1996-04-04
DE69333511D1 (de) 2004-06-17
JP4368406B2 (ja) 2009-11-18
CA2120342C (fr) 2004-11-16

Similar Documents

Publication Publication Date Title
JP4135996B2 (ja) エプスタイン−バールウイルスに関連するペプチド及び核酸配列
JP4612071B2 (ja) エプスタイン−バールウイルスペプチド及び該ペプチドに対する抗体
JP4957974B2 (ja) エプスタイン・バールウイルスのペプチド及びこれらのペプチドに対する抗体
AU735981B2 (en) Peptide reagent for the detection of human cytomegalovirus (CMV)
US6008327A (en) Peptides and nucleic acid sequences related to the Epstein Barr virus
CA2259967C (fr) Reactif de peptides permettant la detection de cytomegalovirus (cmv) humain

Legal Events

Date Code Title Description
MA Patent expired